omeprazole


Also found in: Dictionary, Thesaurus, Wikipedia.
Related to omeprazole: ranitidine, Losec

omeprazole

 [o-mep´ra-zōl]
a proton pump inhibitor, used in treatment of dyspepsia, gastroesophageal reflux disease, disorders of gastric hypersecretion, and peptic ulcer, including that associated with Helicobacter pylori infection; administered orally.

omeprazole

/omep·ra·zole/ (o-mep´ra-zōl) an inhibitor of gastric acid secretion used in the treatment of dyspepsia , gastroesophageal reflux disease, disorders of gastric hypersecretion, and peptic ulcer, including that associated with Helicobacter pylori infection.

omeprazole

(ō-mĕp′rə-zōl′)
n.
A proton pump inhibitor drug, C17H19N3O3S, that suppresses gastric acid secretion and is used for the treatment of duodenal and gastric ulcers and gastroesophageal reflux disease.

omeprazole

Prilosec® Therapeutics A proton pump inhibitor used to manage GERD; heartburn; erosive esophagitis; maintenance of healed erosive esophagitis; short-term management of active duodenal ulcer and active benign gastric ulcer, and for certain hypersecretory conditions; combined with clarithromycin to eradicate H pylori associated with duodenal ulcers. See GERD, Helicobacter pylori. Cf H2 blockers.

omeprazole

The first of the class of proton pump inhibitor drugs used to control the production of stomach acid and treat stomach and duodenal ulcers and especially the ZOLLINGER-ELLISON SYNDROME. OMEPRAZOLE can be effective in cases that have failed to respond to H-2 receptor blocker drugs such as RANITIDINE. The drug is long-acting and need only be taken once a day. A brand name is Losec.

omeprazole (ōmep´rəzōl´),

n brand name: Prilosec;
drug class: antisecretory compound;
action: suppresses gastric secretion by inhibiting hydrogen/potassium ATPase enzyme system in the gastric parietal cell;
uses: gastroesophageal reflux disease (GERD), severe erosive esophagitis, pathologic hypersecretory conditions (Zollinger-Ellison syndrome, mastocytosis, multiple endocrine adenomas).

omeprazole

a substituted benzimidazole that is a long-acting inhibitor of gastric ATPase; used in the treatment of gastric ulcers.
References in periodicals archive ?
Patients in the test group were treated by omeprazole (Actavis (Fushan) Pharmaceutical Co.
MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) tetrazolium reduction assays were performed to evaluate the survival of cells in the presence of omeprazole and esomeprazole Different concentrations of omeprazole and esomeprazole were used to determine the exact drug concentration that could allow 80%-90% cell survival.
They also did not find statistically significant difference in intragastricpH with the use of omeprazole and esomeprazole.
Conclusion: Administration of omeprazole for a short duration does not affect absorption of orally administered iron in healthy individuals.
The most prescribed PPI in the population was omeprazole (20 mg), followed by esomeprazole (20 mg and 40 mg), but other PPIs were also prescribed in lesser quantities.
1% with omeprazole, significantly lower than the 2.
9% Olanzapine levels increased because of loss of interaction between metoprolol, a CYP 2D6 substrate, and olanzapine 24% Rebound from abrupt discontinuation of the beta blocker is causing extrapyramidal symptoms and akathisia 42% Olanzapine levels increased after he stopped taking omeprazole, a potent CYP 1A2 inhibitor 25% Olanzapine levels increased because greater stomach acidity enhanced absorption following discontinuation of the proton pump inhibitor * Data obtained via CurrentPsychiatry.
Omeprazole is a benzimidazole compound used for the treatment of gastrointestinal diseases, especially peptic ulcer.
The case is In Re Omeprazole Patent Litigation, 2007-1414; 1416, 1458, and 1459 Court of Appeals for the Federal Circuit (Washington).
In one study; 9 of 12 children age 1-2 years experienced a decrease of at least 50% in vomiting and/or regurgitation episodes after 8 weeks of omeprazole treatment.